Method for the treatment of Schwann cells in vivo

Details Method for the treatment of Schwann cells in vivo Method for the treatment of Schwann cells in vivo

1996-12-05

1998-12-15

Walsh, Stephen

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

A61K 3818

Patent

active

058497056

ABSTRACT:
Schwann cells can be treated in vivo to survive longer and to proliferate by contacting them with peptides derived from the EGF-like domain of proteins of the NDF/heregulin family.

REFERENCES:
Peles et al., Cell, vol. 69, pp. 205-216 (1992).
Holmes et al., Science, vol. 256 pp. 1205-1210 (1992).
Marchionni et al., Nature, vol. 362, pp. 312-318 (1993).
Falls et al., Cell, vol. 72, pp. 801-815 (1993).
Orr-Urtreger et al., Proc. Natl. Acad. Sci. USA, vol. 90, pp. 1867-1871 (1993).
Wen et al., Mol. and Cell. Biol., vol. 14, No. 3, pp. 1909-1919 (1994).
Wen et al., Cell, vol. 69, pp. 559-572 (1992).
Bacus et al. Cancer Research, vol. 53, pp. 5251-5261 (1993).
Kita et al., FEBS Letters, vol. 349, pp. 139-143 (1994).
Plowman et al., Nature, vol. 366, pp. 473-475 (1993).
Carraway et al., Journal of Biological Chemistry, vol. 269, No. 19, pp. 14303-1436 (1994).
Carraway et al., Cell, vol. 78 pp. 5-8 (1994).
Bacus et al., Cell Growth & Differentiation, vol. 3, pp. 401-411 (1992).

Affiliated with

Also associated with

Rating

Method for the treatment of Schwann cells in vivo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the treatment of Schwann cells in vivo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of Schwann cells in vivo will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1457936